Geno Focus Inc. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
6,421
5,381
10,161
35,870
23,530
Total Accounts Receivable
660
2,375
706
2,046
3,912
Inventories
272
314
435
581
2,073
Other Current Assets
11
307
427
293
644
Total Current Assets
7,365
8,376
11,729
38,790
30,160
Net Property, Plant & Equipment
943
5,729
13,458
17,359
28,803
Total Investments and Advances
37
143
1,149
595
2,088
Intangible Assets
656
1,789
3,189
4,463
6,690
Other Assets
-
-
-
870
1,406
Total Assets
9,000
17,250
30,523
63,226
70,151
ST Debt & Current Portion LT Debt
663
3,013
-
-
1,401
Accounts Payable
18
117
218
46
308
Income Tax Payable
11
41
49
38
-
Other Current Liabilities
166
320
350
498
528
Total Current Liabilities
859
3,491
617
581
2,237
Long-Term Debt
5,488
3,513
-
-
1,200
Deferred Taxes
-
904
998
1,147
1,003
Other Liabilities
-
50
50
128
153
Total Liabilities
6,347
7,363
667
710
3,590
Common Equity (Total)
2,351
9,661
29,787
62,516
64,219
Total Shareholders' Equity
2,351
9,661
29,787
62,516
64,219
Total Equity
2,351
9,661
29,787
62,516
66,561
Liabilities & Shareholders' Equity
9,000
17,250
30,523
63,226
70,151
Accumulated Minority Interest
-
-
-
-
2,343
Non-Equity Reserves
302
226
70
-
-

About Geno Focus

View Profile
Address
Unit 201, Migun Techno World II
Daejeon DE 34014
Korea, Republic Of
Employees -
Website http://www.genofocus.com
Updated 09/14/2018
GenoFocus, Inc. engages the research and development of technologies related to biochemical and biotechnology industry. Its products include enzymes for food, animal, bioconversion and edible vaccines. In addition, It also provides technical services such as library generation, high-throughput screening and consulting services.